Jeil Pharma Holdings Inc (KRX:002620)
South Korea flag South Korea · Delayed Price · Currency is KRW
9,180.00
+80.00 (0.88%)
At close: Jul 18, 2025, 3:30 PM KST

Jeil Pharma Holdings Company Description

Jeil Pharma Holdings Inc manufactures and sells ingredients of drugs, incrementally modified drugs, and generic drugs in South Korea.

The company offers active pharmaceutical ingredients in the areas of antibiotics, gastrointestinal, cardiovascular, neuropsychiatry, oncology, endocrinology, urology, antiviral, and antihistamines, as well as patch products.

It also provides finished dosage forms in the areas of anti-bacteria and anti-fungal, anti-virus, cardiovascular, endocrinology, neurology, gastrointestinal, urology, oncology, anti-histamine, rheumatology, respiratory, otolaryngological, heaptic, laxatives, and purgatives.

The company exports its products to approximately 40 countries in the Association of Southeast Asian Nations, Central and South America, Africa, etc. The company was founded in 1959 and is headquartered in Seoul, South Korea.

Jeil Pharma Holdings Inc
Jeil Pharma Holdings logo
CountrySouth Korea
Founded1959
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees37
CEOSeung-Soo Han

Contact Details

Address:
343, Sapyeong-daero
Seoul, 06543
South Korea
Phone82 2 549 7451
Websitejeilpharm.co.kr

Stock Details

Ticker Symbol002620
ExchangeKorea Stock Exchange
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyKRW
ISIN NumberKR7002620003
SIC Code2834

Key Executives

NamePosition
Seung-Soo HanChairman of The Board and Chief Executive Officer